Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Neurovascular Intervention Devices Market Projected to Reach $6.21 billion by 2030 - Exclusive Report by 360iResearch

This image opens in the lightbox

News provided by

360iResearch

02 May, 2024, 14:03 GMT

Share this article

Share toX

Share this article

Share toX

PUNE, India, May 2, 2024 /PRNewswire/ -- The report titled "Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Indication, End-use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $4.01 billion in 2023 to reach $6.21 billion by 2030, at a CAGR of 6.46% over the forecast period.

"The Advancement of Minimally Invasive Devices Across the Globe"

Neurovascular disorders, conditions impacting the blood vessels of the brain and nervous system, are at the forefront of medical innovation with the advent of neurovascular intervention devices. Designed for precision, these devices, including stents, embolic coils, and clot retrieval tools, facilitate minimally invasive approaches to treat critical conditions such as aneurysms and strokes, significantly improving patient recovery times and outcomes. The demand for such advanced treatments is on a sharp rise due to the increasing incidence of neurovascular diseases globally, coupled with a growing preference for procedures that are less invasive than traditional surgery. This shift emphasizes the critical need for highly skilled specialists and state-of-the-art healthcare facilities, although challenges remain, including improved device navigability through complex vascular structures. Breakthroughs in technology, including the integration of AI and robotics, promise enhanced procedural accuracy and patient care. Regionally, the Americas lead with robust healthcare infrastructure and a focus on innovation, while the Asia-Pacific region witnesses rapid growth driven by healthcare development and an aging demographic. Europe's standardized regulatory framework supports the seamless introduction of safe, effective devices. This global landscape showcases a concerted effort towards advancing neurovascular care, prioritizing patient safety, and accessibility to cutting-edge treatments.

Download Sample Report @ https://www.360iresearch.com/library/intelligence/neurovascular-intervention-devices

"The Rise of Minimally Invasive Treatments"

The medical landscape is rapidly transforming, with an increasing emphasis on minimally invasive procedures, especially for neurovascular care. These innovative techniques highlight the remarkable progress in medical technology and approach, offering patients with required delicate brain and nerve treatments. Traditional surgeries, minimally invasive neurovascular interventions involve smaller incisions, leading to significantly less tissue damage, reduced infection risks, and a quicker recovery period. This shift not only elevates patient outcomes but also contributes to decreased healthcare costs, shorter hospital stays, and heightened patient satisfaction. The convergence of clinical benefits and technological advancements is propelling the need for these procedures, marking a pivotal turn in patient care and healthcare provider preferences.

"The Role of Neurovascular Intervention Devices in Modern Medicine"

Neurovascular intervention devices play a crucial role in stroke prevention and treatment in enhancing patient care. These tools, including balloon systems for angioplasty, ensure the reopening of narrowed or blocked brain arteries, improving blood circulation. Carotid stents support arteries to prevent collapse, which is crucial in preventing strokes in patients diagnosed with severe artery stenosis. Neurovascular catheters deliver essential drugs and devices precisely within the brain's intricate vasculature, aiding in various treatments. Embolic coils offer a preventive approach to brain aneurysms by promoting clot formation, thereby preventing rupture. Embolic protection devices safeguard patients by capturing debris during procedures, minimizing stroke risks. Flow diverters are revolutionizing the treatment of complex aneurysms by redirecting blood flow, leading to safer and more effective outcomes. Guidewires provide the necessary navigation within the brain's delicate arterial network, facilitating the accurate placement of these devices. Intracranial stents are essential in maintaining open blood vessels for patients with intracranial stenosis. Intrasaccular devices provide an innovative solution for aneurysm management, disrupting blood flow to encourage occlusion. Neurothrombectomy devices have transformed acute ischemic stroke treatment, allowing for the direct removal of clots. Stent retrievers efficiently extract large clots, representing a critical step forward in stroke management. These advances emphasize a promising direction in neurovascular care, emphasizing innovative, life-saving strategies.

Request Analyst Support @ https://www.360iresearch.com/library/intelligence/neurovascular-intervention-devices

"Stryker Corporation at the Forefront of Neurovascular Intervention Devices Market with a Strong 14.84% Market Share"

The key players in the Neurovascular Intervention Devices Market include Terumo Corporation, Stryker Corporation, Medtronic PLC, Penumbra, Inc., Johnson & Johnson Services, Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.

"Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Neurovascular Intervention Devices Market"

We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Neurovascular Intervention Devices Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Neurovascular Intervention Devices Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.

Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/neurovascular-intervention-devices

"Dive into the Neurovascular Intervention Devices Market Landscape: Explore 186 Pages of Insights, 490 Tables, and 24 Figures"

  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Neurovascular Intervention Devices Market, by Product
  7. Neurovascular Intervention Devices Market, by Process
  8. Neurovascular Intervention Devices Market, by Indication
  9. Neurovascular Intervention Devices Market, by End-use
  10. Americas Neurovascular Intervention Devices Market
  11. Asia-Pacific Neurovascular Intervention Devices Market
  12. Europe, Middle East & Africa Neurovascular Intervention Devices Market
  13. Competitive Landscape
  14. Competitive Portfolio

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/neurovascular-intervention-devices

Related Reports:

  1. Neurovascular Catheters Market - Global Forecast 2024-2030
  2. Brain Imaging Modalities Market - Global Forecast 2024-2030
  3. Neurovascular Devices Market - Global Forecast 2024-2030

About 360iResearch

Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

Contact 360iResearch
Mr. Ketan Rohom
360iResearch Private Limited,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
Email: sales@360iresearch.com
USA: +1-530-264-8485
India: +91-922-607-7550

To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.

Logo: https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.